[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cardiometabolic-health-indicators\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cardiometabolic-health-indicators":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,45,85,109,145,190,213,243],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":27,"conditions":28,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100614655","phase-1-behavioral-economic-attributes-of-recreation-100614655",false,"NCT07282418","Behavioral Economic Attributes of Recreation","Behavioral Economic Attributes of Recreation (BEAR): A Pilot Trial Within a Ccohort","BEAR","Eligibility criteria for BEAR main cohort enrollment (N=120):\n\n* Age 18 years or older\n* Fluent in English\n* Lives within 10 miles of the study site\n* Not planning to move outside the study region in the next 6 months\n* Has a working Android or iOS mobile device they are willing to use for EMA surveys and communication with the study team\n* No apparent cognitive deficits that would suggest a lack of capacity to consent or complete study procedures\n* No uncontrolled serious mental illness, marked by an inpatient hospitalization, increase or change in antipsychotic or mood stabilizing medication, or suicidal intent in the past 6 months.\n\nEligibility for selection into the RCT component (n=60):\n\n* At least 75% adherence to EMA surveys during the initial assessment\n* Complete baseline data within the observational cohort component\n* Participant endorses engagement in recreation less than 4 times per week based on EMA surveys\n* LE8 score \\\u003C70, reflecting low to moderate cardiometabolic health.\n* No serious substance abuse problem based on an ASSIST score of ≥27 for any substance other than tobacco or cannabis\n* Willing and able to try recreational activities for the next 6 months",true,"ALL","18 Years",{"count":21,"type":22},120,"ESTIMATED","INTERVENTIONAL",[25,26],"PHASE1","PHASE2","Risk for developing and dying from heart disease, type 2 diabetes, stroke, and other cardiometabolic conditions is strongly influenced by behavioral risk factors, including poor diet, physical inactivity, and tobacco and alcohol abuse. Behavioral economic models predict engagement in these behaviors as a function of their subjective value, ability to provide immediate gratification, and availability of competing alternatives. A key implication of the behavioral economic model is that increasing the accessibility of compelling alternative sources of reinforcement may displace engagement in unhealthy behaviors. Developing interventions that leverage these insights requires both a clear understanding of the characteristics of the \"reward landscape\" of U.S. adults, and the impact of altering the reward landscape on behavioral economic processes and health behavior.\n\nThis pilot study uses a trial within a cohort (TwiC) design to pursue these objectives. A representative sample of adults (N=120) will be enrolled into an observational cohort. Cardiometabolic health will be assessed and quantified based on the Life's Essential 8 (LE8) scoring system,4 which includes 4 behavioral (physical activity, diet quality, sleep, tobacco use) and 4 biomedical (non-HDL cholesterol, glucose, weight status, and blood pressure) factors. Structured home audit tools and an ecological momentary assessment (EMA) protocol will be used to measure environmental access to, demand for, and engagement in various rewarding activities, including different categories of recreational activity, electronic entertainment, social activities, and consumable rewards including food, tobacco products, and alcohol. The inter-relationships between different types of rewarding behaviors as substitutes or complements, and their links with cardiometabolic health, will be examined overall and with stratification by socioeconomic status.\n\nFollowing completion of the first assessment, a subset of participants will be selected for randomization to a recreation-focused intervention or continued observation within the cohort based on their baseline status and protocol adherence. In TwiC designs, the \"control\" group simply continues to complete observational assessments within the cohort and is not notified that an intervention is ongoing. The BEAR \"intervention\" group will be approached for consent to participate in a 6-month behavioral economic intervention in which recreational activities are promoted as a strategy to displace cardiometabolic risk behaviors. The scientific aims of the randomized trial component of the study include examining change in LE8 scores, demand for various rewarding activities, discounting rates, and health behaviors. BEAR will also address several feasibility aims, including demonstrating the ability to measure and categorize access to rewarding activities, document recreation-related expenditures by participants, and estimate intervention uptake and acceptability.",[29],"Cardiometabolic Health Indicators",[31],"recreation","RECRUITING","2026-06-16",{"date":35,"type":36},"2026-06-18","ACTUAL",{"date":38,"type":36},"2026-05-11",{"date":40,"type":22},"2027-06-30",{"name":42,"class":43},"Rush University Medical Center","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":17,"sex":18,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":23,"phases":56,"briefSummary":58,"conditions":59,"keywords":63,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":44},"100642187","pulse-education-and-children-100642187","NCT07648446","Pulse Education and Children","Enhancing Dietary Perception and Acceptance of Pulses in Children Through an Innovative Nutritional Intervention Program: Bringing Pulses to the Dining Table","Inclusion Criteria:\n\n* Children aged 6-13 years old\n* Ability to speak English\n\nExclusion Criteria:\n\n* Frequent pulse consumers (\\>0.5 cup\u002Fweek for females and \\>1 cup \u002F week for males)\n* Antibiotic use in the past 3 months\n* Diagnosed metabolic\u002Fgut diseases (ulcerative colitis, Crohn's disease, diverticulosis, peptic ulcers, small intestinal bacterial overgrowth, short bowel syndrome, irritable bowel syndrome, gastroesophageal reflux disease), neurological (multiple sclerosis, meningitis, recent stroke) or endocrine disorders (uncontrolled thyroid disorders, growth hormone disorders, adrenal gland disorders, uncontrolled diabetes - A1C \\> 9%).\n* Current use of medications or nutrition supplements\n* Individuals following a specific dietary patten\n* Individuals who gained or lost \\>5% body weight within the past 6 months\n* Those involved in another study concurrently\n* Any allergies to pulses\n* Intake of pre\u002Fpro\u002Fpostbiotics in the past 3 months","6 Years","13 Years",{"count":55,"type":22},60,[57],"NA","This parallel-arm, randomized controlled trial will evaluate the effectiveness of a 6-week pulse-focused nutrition intervention in school-aged children (6-13 years). The study aims to assess adherence to a pulse-based diet providing 1.5 cups of pulses per week and to examine the effects of whole-cooked pulse consumption on gut health, including gut microbiome composition, metabolomic profiles, and gut barrier function. Secondary objectives include evaluating the impact of pulse consumption on markers of metabolic health and inflammation. Forty participants will be randomized to either a pulse-focused nutrition education program with weekly provision of pre-measured pulses (black beans, lentils, and chickpeas) or a pulse-focused nutrition education program in which participants independently procure their own pulses. Participants will follow the assigned intervention for 6 weeks.",[60,29,61,62],"Dysbiosis","Education on Feeding and Health Status","Gut Motility",[64,65,66,67,68,69,70,71,72,73,74,75],"gut","git microbiome","children","pediatric","pulses","beans","metabolomics","nutrition education","dietary adherence","fiber inake","plant-based","pulse consumption","2026-06-11",{"date":78,"type":36},"2026-06-15",{"date":80,"type":22},"2026-08-01",{"date":82,"type":22},"2028-12-31",{"name":84,"class":43},"Florida State University",{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":17,"sex":18,"minAge":52,"maxAge":53,"enrollmentInfo":92,"targetDuration":4,"studyType":23,"phases":94,"briefSummary":95,"conditions":96,"keywords":97,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":107,"leadSponsor":108,"locationsCount":44},"100642795","almonds-gut-microbiome-and-kids-100642795","NCT07636850","Almonds, Gut Microbiome and Kids","Nutritional Impact of Almond Butter on Gut Microbiome and Cardiometabolic Health in School-Aged Children: A Novel and Timely Pilot Randomized Controlled Trial","Inclusion Criteria:\n\n* Enrolled in elementary or middle school (grades 1-8)\n* Aged 6-13 years old\n* Ability to speak and read in English\n\nExclusion Criteria:\n\n* Intake of antibiotics in the last 3 months\n* Intake of pre\u002Fpro\u002Fpostbiotics in the last 3 months\n* Food allergy to study foods\n\n  ◦ Any allergy to nuts or almonds\n* Any allergy to the isocaloric snack (chocolate or wheat)\n* Regular consumption of nuts or almonds greater than 2 servings \u002F week\n* Gastrointestinal disease (ulcerative colitis, Crohn's disease, diverticulosis, peptic ulcers, small intestinal bacterial overgrowth, short bowel syndrome, irritable bowel syndrome, gastroesophageal reflux disease), neurological (multiple sclerosis, meningitis, recent stroke) or endocrine disorders (uncontrolled thyroid disorders, growth hormone disorders, adrenal gland disorders, uncontrolled diabetes - A1C \\> 9%).",{"count":93,"type":22},70,[57],"This 8-week parallel-arm randomized controlled trial (N=70; ages 6-13) will determine the impact of daily almond butter consumption on gut microbiome composition and function, intestinal barrier integrity, and cardiometabolic health in school-aged children. Participants will be randomized to either a once-daily snack of personalized-portion almond butter (ALB; 16g, Creamy Natural Almond Butter) or an isocaloric nut-free chocolate spread control (CTL; 16g, Cadbury Milk Chocolate), each served on two plain unsalted saltine crackers, added to their habitual diet. The primary outcomes include oro-gut microbial composition and diversity, gut microbial functional capacity and metabolomics (SCFAs, bile acids, amino acid metabolites), and intestinal barrier integrity. Secondary outcomes include fasting cardiometabolic markers, systemic inflammation, appetite-regulatory and metabolic hormones, and sleep-related biomarkers. Feasibility, adherence (weekly logs; serum α-tocopherol), and precision nutrition potential will also be assessed, with stratified analyses by age, sex, BMI, ethnicity, and pubertal stage.\n\nThis pilot trial will generate the first multi-omics characterization of almond butter's effects on the gut-immune-metabolic axis in children.",[60,29],[64,98,66,67,99,100,101,102,70],"gut microbiome","sleep quality","almonds","nuts","almond butter","2026-06-05",{"date":105,"type":36},"2026-06-09",{"date":80,"type":22},{"date":82,"type":22},{"name":84,"class":43},{"id":110,"slug":111,"hasResults":11,"nctId":112,"briefTitle":113,"officialTitle":114,"acronym":115,"eligibilityCriteria":116,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":117,"enrollmentInfo":118,"targetDuration":4,"studyType":23,"phases":120,"briefSummary":121,"conditions":122,"keywords":127,"overallStatus":134,"whyStopped":4,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":44},"100623383","resveratrol-effects-on-inflammatory-biomarkers-and-cardiometabolic-parameters-100623383","NCT07395921","Resveratrol Effects on Inflammatory Biomarkers and Cardiometabolic Parameters.","Effects of Resveratrol Supplementation on Inflammatory Biomarkers and Cardiometabolic Parameters in Community-dwelling Adults. (RESINCA-trial)","RESINCA","Inclusion Criteria:\n\n* Comunnity-dwelling persons.\n* Any ethnicity.\n* With willingness to consume the bar daily during the intervention period.\n\nExclusion Criteria:\n\n* Allergy\u002Fintolerance to ingredients in the bar.\n* Pregnancy or breastfeeding.\n* Use of antioxidant\u002Fpolymeroid supplements in the last 4 weeks.\n* Unstable chronic diseases (e.g., severe liver failure, advanced kidney failure, active cancer).\n* Persons in treatments that strongly interfere with polyphenol metabolism (e.g., antibiotics, anti-inflammatories, corticosteroids, anti-allergy medication).\n* Persons with metal prosthesis.\n* Persons undergoing or waiting for metabolic bariatric surgery.\n* Persons with scheduled digestive surgery within the next 8 weeks\n* Persons in recent treatments for hypertension (less than 3 month).\n* Participation in another clinical trial.","65 Years",{"count":119,"type":22},75,[57],"This study aims to evaluate the effect of the supplementation of grape pomace bars enriched in resveratrol on inflammatory biomarkers and cardiometabolic parameters in community-dwelling adults",[123,29,124,125,126],"Inflammation Biomarkers","Antioxidant Status, Inflammation","Antioxidant Capabilities","Inflammaging",[128,129,130,131,132,133],"Resveratrol","inflammation","inflammaging","antioxidant","cardiometabolic health","nutritional intervention","NOT_YET_RECRUITING","2026-05-18",{"date":137,"type":36},"2026-05-19",{"date":139,"type":22},"2026-06-01",{"date":141,"type":22},"2026-12-01",{"name":143,"class":144},"Center for Research and Innovation Viña Concha y Toro","INDUSTRY",{"id":146,"slug":147,"hasResults":11,"nctId":148,"briefTitle":149,"officialTitle":150,"acronym":4,"eligibilityCriteria":151,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":152,"targetDuration":154,"studyType":155,"phases":4,"briefSummary":156,"conditions":157,"keywords":170,"overallStatus":134,"whyStopped":4,"lastUpdateSubmitDate":181,"lastUpdatePostDateStruct":182,"startDateStruct":184,"completionDateStruct":186,"leadSponsor":188,"locationsCount":4},"100630769","development-and-multicenter-validation-of-an-ai-based-remote-photoplethysmography-rppg-facial-scan-for-multimodal-health-assessment-100630769","NCT07491978","Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment","Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment: Agreement With Clinical, Laboratory, and Psychological Parameters in an Urban Population","Inclusion Criteria:\n\n1. Adults aged ≥18 years.\n2. Able and willing to provide written informed consent.\n3. Able to comply with study procedures, including face scan, physical examination, blood sampling, and questionnaire completion.\n4. Clinically stable at the time of assessment.\n\nExclusion Criteria:\n\n1. Facial conditions affecting the region of interest (ROI), such as injury, deformity, or impaired circulation, that may interfere with rPPG signal acquisition.\n2. Presence of facial tattoos or coverings that obstruct optical signal detection.\n3. Inability to remain still or comply with measurement procedures during data acquisition.\n4. Severe medical conditions that preclude safe participation, as judged by the investigator.\n5. Incomplete data or withdrawal of consent during the study.\n\n   \\-",{"count":153,"type":22},1000,"1 Day","OBSERVATIONAL","The goal of this observational study is to learn if a non-contact facial scan using artificial intelligence (AI) can be used to check health status in adults living in urban areas such as Jakarta. The facial scan uses a method called remote photoplethysmography (rPPG), which measures small changes in blood flow from the face using a camera.\n\nThe main questions this study aims to answer are:\n\n1. How close are the results from the facial scan to standard medical measurements, such as heart rate, breathing rate, blood pressure, and oxygen levels?\n2. Can the facial scan estimate other health indicators, such as blood sugar, lipid profile, HbA1c, and hemoglobin levels?\n3. Is there a relationship between the facial scan results and mental health, such as stress, anxiety, and depression?\n\nParticipants will take part in several simple and mostly non-invasive procedures:\n\n1. Answer questionnaires about their mental health and daily habits\n2. Have basic health checks, such as blood pressure, heart rate, and body measurements\n3. Provide a blood sample for laboratory testing\n4. Complete a facial scan using a camera for about 1 to 3 minutes\n\nResearchers will compare the results from the facial scan with standard clinical and laboratory tests to see how well the technology works.\n\nThis study may help develop a simple and accessible screening tool that can be used for early detection of health risks. It may also support the use of digital health and telemedicine in community and clinical settings.",[158,159,160,161,162,163,164,165,166,167,29,168,169],"Metabolic Syndrome","Hypertension","Diabetes (DM)","Tachycardia","ASCVD","Depression Disorder","Anxiety","Stress (Psychology)","Obesity & Overweight","Cardiometabolic Risk Factors","Sleep","Wellness",[171,172,173,174,175,176,177,178,179,180],"remote photoplethysmography","rPPG","artificial intelligence","digital biomarker","telemedicine","vital signs","cardiometabolic risk","machine learning","facial scan","screening tool","2026-04-15",{"date":183,"type":36},"2026-04-20",{"date":185,"type":22},"2026-04-24",{"date":187,"type":22},"2027-03-30",{"name":189,"class":43},"Tarumanagara University",{"id":191,"slug":192,"hasResults":11,"nctId":193,"briefTitle":194,"officialTitle":195,"acronym":4,"eligibilityCriteria":196,"healthyVolunteers":17,"sex":197,"minAge":4,"maxAge":4,"enrollmentInfo":198,"targetDuration":4,"studyType":23,"phases":200,"briefSummary":201,"conditions":202,"keywords":4,"overallStatus":134,"whyStopped":4,"lastUpdateSubmitDate":204,"lastUpdatePostDateStruct":205,"startDateStruct":207,"completionDateStruct":209,"leadSponsor":211,"locationsCount":44},"100593453","effect-of-watermelon-on-cardiometabolic-health-100593453","NCT07006636","Effect of Watermelon on Cardiometabolic Health","Effect of Watermelon Consumption on Cardiometabolic Health and Whole-Body Antioxidant Capacity","Inclusion Criteria:\n\n* Female\n* Generally healthy\n* Postmenopausal\n* BMI 25-40 kg\u002Fm2\n* Systolic blood pressure 120-139 mmHg and\u002For diastolic 80-89 mmHg\n* Fitzpatrick Skin type II-IV\n* Consume a typical Western diet (low in polyphenol\u002Flycopene-rich foods and fiber)\n* Willing to maintain habitual dietary and exercise patterns for the study duration\n* Willing to maintain normal skin care products and pattern for the duration of the study\n* Willing to come to Baseline Visit B and Week 4 study visits without any makeup and skin products on\n* Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.\n\nExclusion Criteria:\n\n* Non-English speaker\n* Vegetarian\u002Fvegan\n* Known watermelon allergy\n* Skin-related prescription medication, supplements, or non-prescription cosmeceutical agents\n* Initiation of topical or oral prescription steroids and\u002For anti-inflammatory medications within 30 days prior to study enrollment\n* Excessive exposure to either natural or artificial sunlight. Exposure to sunlight will be evaluated using Fitzpatrick Skin Type test score. Individuals receiving scores higher than the upper cutoff of the proposed range for the specific skin type will be excluded\n* Screening laboratory values outside of the normal range that is considered clinically significant for study participation by the investigator\n* Documented chronic disease, including diabetes, renal or liver diseases, metabolic syndrome, active cancer, MI or stroke, history of gastric bypass or GI disease (e.g., Crohn's disease, IBD, diverticulosis, diverticulitis, etc.)\n* Taking medications or supplements known to affect metabolism or gut microbiota composition (antibiotics within the past 3 months, probiotics, fiber, etc.), unless willing to stop for the study duration\n* Taking exogenous hormones (e.g., hormone replacement therapy)\n* Recent weight fluctuations (\\>10% in the last 6 months)\n* Smoker or living with a smoker\n* Use of \\>20 g of alcohol per day\n* Unable or unwilling to comply with the study protocol (including unwillingness to avoid watermelon and other lycopene-rich foods for the whole duration of the study)\n* Unable to provide consent","FEMALE",{"count":199,"type":22},22,[57],"The purpose of this study is to determine whether consumption of 355 ml of watermelon juice will:\n\n1. improve cardiovascular and overall metabolic health markers like blood pressure, heart rate, stiffness\u002Fflexibility of arteries (blood vessels), blood sugar, cholesterol), and gut hormones\n2. contribute to the body's ability to protect itself from the potential cell damage caused by harmful chemical compounds (produced when skin is exposed to ultraviolet (UV) B light, for example). This will be evaluated by measuring how resistant skin is to the damage from UVB light exposure, as well as several markers of bodily stress blood and urine.\n\nThis will be determined immediately after consuming the juice (to evaluate the effects the juice has on health right away), as well as after 4 weeks of daily juice consumption (to evaluate the effects the juice has on health when consumed consistently over time).",[29,203],"Whole-body Antioxidant Capacity","2026-03-10",{"date":206,"type":36},"2026-03-12",{"date":208,"type":22},"2026-04-01",{"date":210,"type":22},"2027-09-01",{"name":212,"class":43},"University of California, Los Angeles",{"id":214,"slug":215,"hasResults":11,"nctId":216,"briefTitle":217,"officialTitle":218,"acronym":4,"eligibilityCriteria":219,"healthyVolunteers":17,"sex":18,"minAge":220,"maxAge":221,"enrollmentInfo":222,"targetDuration":4,"studyType":23,"phases":224,"briefSummary":225,"conditions":226,"keywords":229,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":234,"lastUpdatePostDateStruct":235,"startDateStruct":237,"completionDateStruct":239,"leadSponsor":241,"locationsCount":44},"100602552","mango-intake-and-gut-and-cardiometabolic-health-in-hispaniclatino-adolescents-100602552","NCT07125001","Mango Intake and Gut and Cardiometabolic Health in Hispanic\u002FLatino Adolescents","The Influence of Mango-Derived Intestinal Microbial Metabolites on Gut Permeability, Inflammation, and Cardiometabolic Health Markers in Hispanic\u002FLatino Adolescents","Inclusion Criteria:\n\n* \\- Male or Female 12-19 years old\n* BMI ≥ 85th percentile (https:\u002F\u002Fwww.bcm.edu\u002Fbodycomplab\u002FBMIapp\u002FBMI-calculator-kids.html)\n* Self-reported Hispanic\u002FLatino\n* Subject is willing and able to comply with the study protocols\n* Subject is willing to consume the test products\n* Female-specific criteria: if menstruating, eumenorrheic (regular monthly menstrual cycles of 25-30-days in length)\n* Access to a smartphone or tablet at least 1x \u002F day and willing to take pictures associated with the products to be consumed in the study\n\nExclusion Criteria:\n\n* \\- Reported food allergies.\n* Currently taking prescription drugs, with the exception of asthma inhalers, which are allowed\n* BMI \\\u003C85th percentile (https:\u002F\u002Fwww.bcm.edu\u002Fbodycomplab\u002FBMIapp\u002FBMI-calculator-kids.html)\n* Current participation in a moderate or high-intensity daily exercise routine\n* Self-reported disease, serious illness, or who are currently under acute medical care.\n* Currently taking prescription drugs.\n* Any supplement use, including multi-vitamin\u002F mineral, herbal, plant or botanical, fish oil, and oil supplements, and not willing to discontinue before starting the study.\n* Vegetarian or vegan diet\n* Self-reported malabsorption or gastrointestinal issues\n* Fruit and vegetable intake exceeding daily recommendations of 5 servings\n* Smoking (vaping, conventional nicotine-containing products or marijuana)\n* Current enrollee in a clinical research study","12 Years","19 Years",{"count":223,"type":22},25,[57],"Mangos contain a number of nutrients that may improve gut and metabolic health. The purpose of this research is to see how eating mangos every day for 4 weeks instead of snacks high in calories and low in nutrients such as cookies, crackers, chips, and candy can impact adolescent health.",[29,227,228],"Vascular Function in Healthy Volunteers","Inflammation",[230,231,232,233],"mango","cardiometabolic","adolescents","microbiome","2026-01-29",{"date":236,"type":36},"2026-02-03",{"date":238,"type":36},"2025-10-01",{"date":240,"type":22},"2028-03-31",{"name":242,"class":43},"University of California, Davis",{"id":244,"slug":245,"hasResults":11,"nctId":246,"briefTitle":247,"officialTitle":248,"acronym":249,"eligibilityCriteria":250,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":117,"enrollmentInfo":251,"targetDuration":4,"studyType":155,"phases":4,"briefSummary":253,"conditions":254,"keywords":257,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":267,"lastUpdatePostDateStruct":268,"startDateStruct":270,"completionDateStruct":272,"leadSponsor":274,"locationsCount":276},"100611969","diet-and-cardiometabolism-in-rosario-100611969","NCT07247487","Diet and Cardiometabolism in Rosario","Comparative Analysis of Diet and Cardiometabolic Health in Individuals Following Vegan, Vegetarian, and Omnivorous Diets in the City of Rosario","DiCaMeR","Inclusion Criteria:\n\n* Adults aged 18 to 65 years.\n* Residence in the city of Rosario or surrounding areas.\n* Without major diseases.\n* BMI \\>18.5 and \\\u003C30.\n* Adherence to a vegan, vegetarian, or omnivorous diet for at least 1 consecutive year at the time of recruitment.\n\nExclusion Criteria:\n\n* Acute or chronic diseases (cancer, infections, heart disease, or others), gastrointestinal disorders affecting diet, diabetes mellitus, chronic kidney or liver disease, or any other condition that could affect study outcomes.\n* Food allergies or intolerances that substantially affect the individual's usual diet.\n* Pregnant or breastfeeding women.\n* High-performance athletes (\\>15 hours per week of high-intensity physical activity).\n* Use of medications that could affect study outcomes, including antihypertensives, lipid-lowering drugs, hypoglycemic agents, glucocorticoids, and anti-obesity drugs. Note: vitamin, mineral, or other dietary supplements are not exclusion criteria.\n* Problematic use of alcohol or other drugs.\n* Simultaneous participation in another clinical trial.\n* Inability (physical or psychological) to perform the procedures required by this study.\n* Blood transfusions within the last 3 months.",{"count":252,"type":22},105,"The DiCaMeR study is an observational, cross-sectional study aimed at evaluating the relationship between dietary patterns and cardiometabolic health in adults. The study includes adults following vegan, vegetarian, and omnivorous diets residing in Rosario, Argentina. Participants undergo comprehensive assessments including dietary intake, anthropometric measurements, body composition, blood pressure, grip strenght, and laboratory biomarkers related to cardiovascular and metabolic health. The main objective is to compare diet characteristics and cardiometabolic risk profiles across different dietary patterns, providing insights into the potential health benefits and risks associated with each dietary pattern.",[255,256,29],"Cardiovascular (CV) Risk","Nutrition",[258,259,260,261,262,263,264,256,265,266],"Vegan","Vegetarian","Plant-based","Cardiometabolic health","Cardiometabolism","Cardiovascular health","Diet","Dietary Patterns","Nutrients","2025-11-25",{"date":269,"type":36},"2025-12-03",{"date":271,"type":22},"2025-12-01",{"date":273,"type":22},"2027-12-01",{"name":275,"class":43},"Universidad del Centro Educativo Latinoamericano",2]